Form 144 is an intent-to-sell notice, not a completed trade. Monitor subsequent Form 4 filings to confirm whether the sale actually occurred. For a pre-revenue biotech, insider sales of this size are routine and not indicative of material negative news.
Price Chart
Executive Summary
Jason V. Coloma, an officer of Maze Therapeutics, filed a Form 144 notice of intent to sell 34,501 shares of common stock, with an estimated aggregate market value of approximately $933,252. The shares are held through family trusts and were acquired via gifts in 2021. This is a routine insider sale notice for a pre-revenue biotech, and the filing itself signals only intent, not a completed transaction.
Key Facts
- Insider Jason V. Coloma (Officer) filed Form 144 to sell 34,501 shares of Maze Therapeutics common stock.
- Estimated aggregate market value of proposed sale: $933,252.
- Shares are held through The Coloma 2021 Irrevocable Trust and Coloma Family Trust.
- Shares were originally acquired as gifts on September 22, 2021.
- Filing date: October 1, 2026; proposed sale date also October 1, 2026.
Financial Impact
Proposed sale of 34,501 shares valued at approximately $933,252, a modest amount relative to a typical biotech market cap.
Risk Factors
- Insider sale may signal lack of confidence if executed ahead of material negative catalysts.
- Pre-revenue biotech carries inherent clinical and regulatory risk independent of insider trading patterns.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001969223-26-001044 |
| Document: 0001969223-26-001044-index.html | 0001969223-26-001044 |
| Document: 0001969223-26-001044.txt | 0001969223-26-001044 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 today | 144 | $32.17 | awaiting T+5 | awaiting T+5 | $31.93 (−0.75%) |
Oct 16, 2026 13d ago | 8-K | $29.70 $31.07 | ▲ +4.61% | ▲ +4.76% | $31.93 (+7.51%) |
Oct 2, 2026 28d ago | Insider Cluster | $26.43 $27.70 | ▼ −4.81% | ▼ −4.38% | $31.93 (−20.81%) |
Oct 1, 2026 28d ago | 144 | $26.43 $27.11 | ▲ +2.57% | ▲ +1.41% | $31.93 (+20.81%) |
Sep 8, 2026 7w ago | Insider Cluster | $24.58 $23.92 | ▲ +2.71% | ▲ +1.61% | $31.93 (−29.90%) |
Sep 4, 2026 7w ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $31.93 (+21.08%) |
Sep 4, 2026 7w ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $31.93 (+21.08%) |
Sep 3, 2026 8w ago | Insider Cluster | $26.21 $24.67 | ▼ −5.88% | ▼ −4.67% | $31.93 (+21.82%) |
Sep 2, 2026 8w ago | 144 | $25.87 $24.60 | ▼ −4.91% | ▼ −3.76% | $31.93 (+23.42%) |
Sep 1, 2026 8w ago | 144 | $26.72 $24.82 | ▼ −7.11% | ▼ −6.15% | $31.93 (+19.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers